Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial. - Hamaluba M; Sang S; Orindi B; Njau I; Karanja H; Kamau N; Gitonga JN; Mugo D; Wright D; Nyagwange J; Kutima B; Omuoyo D; et al. (Wellcome open research, 2023)